Bionomics End Period Cash Flow from 2010 to 2024

BNOX Stock  USD 0.30  0.02  7.14%   
Bionomics End Period Cash Flow yearly trend continues to be fairly stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2024. During the period from 2010 to 2024, Bionomics End Period Cash Flow regression line of annual values had r-squared of  0.00000134 and arithmetic mean of  17,878,032. View All Fundamentals
 
End Period Cash Flow  
First Reported
1999-03-31
Previous Quarter
8.4 M
Current Value
8.2 M
Quarterly Volatility
13.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.56. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
  
Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Bionomics Ltd ADR over the last few years. It is Bionomics' End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Very volatile
   End Period Cash Flow   
       Timeline  

Bionomics End Period Cash Flow Regression Statistics

Arithmetic Mean17,878,032
Geometric Mean11,881,115
Coefficient Of Variation55.93
Mean Deviation8,100,565
Median17,336,609
Standard Deviation9,999,147
Sample Variance100T
Range33.8M
R-Value0
Mean Square Error107.7T
R-Squared0.00000134
Significance1.00
Slope2,586
Total Sum of Squares1399.8T

Bionomics End Period Cash Flow History

202415.1 M
202312.7 M
202212.2 M
202123.2 M
202028.5 M
20194.6 M
20189.8 M

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' End Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow12.7 M15.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.